rs74315470
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000487.6(ARSA):c.736C>T(p.Arg246Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000026 in 1,613,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R246H) has been classified as Pathogenic.
Frequency
Consequence
NM_000487.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSA | NM_000487.6 | c.736C>T | p.Arg246Cys | missense_variant | 4/8 | ENST00000216124.10 | NP_000478.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSA | ENST00000216124.10 | c.736C>T | p.Arg246Cys | missense_variant | 4/8 | 1 | NM_000487.6 | ENSP00000216124.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 251026Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135794
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461766Hom.: 0 Cov.: 33 AF XY: 0.0000303 AC XY: 22AN XY: 727182
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Pathogenic:6Other:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant c.736C>T (p.Arg246Cys) in ARSA gene has been observed in individuals affected with metachromatic leukodystrophy (Luzi P et.al.,2013). This variant has been reported to the ClinVar database as Pathogenic. The p.Arg246Cys variant is novel (not in any individuals) in 1000 Genomes and allele frequency of 0.0007967% is reported in gnomAD. The amino acid Arg at position 246 is changed to a Cys changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Arg246Cys in ARSA is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic . - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Jun 19, 2014 | - - |
not provided, no classification provided | in vitro | Gelb Laboratory, University of Washington | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 07, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 246 of the ARSA protein (p.Arg246Cys). This variant is present in population databases (rs74315470, gnomAD 0.002%). This missense change has been observed in individual(s) with metachromatic leukodystrophy (PMID: 22993277, 24001781, 26462614, 28670130). This variant is also known as p.Arg244Cys. ClinVar contains an entry for this variant (Variation ID: 3073). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSA protein function with a positive predictive value of 95%. This variant disrupts the p.Arg246 amino acid residue in ARSA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9090526, 22993277, 25965562, 26462614). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 29, 2019 | - - |
Metachromatic leukodystrophy, juvenile type Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Dec 23, 2022 | This sequence change in ARSA is predicted to replace arginine with cysteine at codon 246, p.(Arg246Cys) (historically described as c.730C>T p.Arg244Cys). The arginine residue is highly conserved (94/94 vertebrates, UCSC), and is located in the sulfatase domain. There is a large physicochemical difference between arginine and cysteine. The highest population minor allele frequency in the population database gnomAD v2.1 is 0.002% (2/113,422 alleles) in the European (non-Finnish) population, which is consistent with a recessive disease. This variant has been detected in the homozygous and compound heterozygous state with a second pathogenic allele in multiple individuals with arylsulfatase A (ASA) deficiency. The phenotype was mainly late-infantile or juvenile metachromatic leukodystrophy (PMID: 9090526, 16966551, 19815439, 22993277, 26462614, 36240581). At least one patient with this variant displayed very low ASA activity in leukocytes and abnormally high sulfatide excretion in urine, which is highly specific for ASA deficiency (PMID: 22993277). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (5/5 algorithms). Another missense variant (c.737G>A p.Arg246His) in the same codon with a smaller physicochemical difference has been classified as likely pathogenic for ASA deficiency (PMID: 26462614, 9090526, 22993277, 25965562). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PM5, PP3, PP4. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at